Abstract:Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injuryJournal of HepatologyVol. 67Issue 6PreviewIschemia-reperfusion injury (IRI) during liver resection, procurement and transplantation, characterized by sterile inflammation and hepatocellular death, represents a risk factor predisposing a patient to acute and chronic rejection.1 As one of the most challenging problems in transplantation, IRI contributes to the shortage of donor organs. The initiating events that account for tissue damage are not well understood. We previously found that Toll-like receptor 4 (TLR4) drives innate immune responses in IR-stressed murine livers. Full-Text PDF Reply to: “Protective effects of heme oxygenase 1 during ischemia-reperfusion injury: Hepatocytes or non parenchymal cells?”Journal of HepatologyVol. 69Issue 3PreviewWe thank Xu et al. for their insightful comments on our recently published papers in Journal of Hepatology1 and American Journal of Transplantation,2 in which we documented the importance of macrophage heme oxygenase-1 (HO-1) on macrophage activation and graft autophagy regulation in the pathophysiology of hepatic ischemia-reperfusion injury (IRI). Full-Text PDF Hepatic ischemia-reperfusion injury (IRI) remains an important issue in clinical procedures such as liver resection and organ transplantation and in the context of trauma and shock. Hepatic IRI may lead to poor early graft function and even acute or chronic organ rejection and may affect long-term patient/graft survival after liver transplantation. Although hepatic IRI is one of the major causes of morbidity and mortality in liver surgery, there are currently no effective therapeutic strategies to protect the liver from IRI. We read with great interest studies by Nakamura et al.1Nakamura K. Zhang M. Kageyama S. Ke B. Fujii T. Sosa R.A. et al.Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury.J Hepatol. 2017; 67: 1232-1242Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar, 2Nakamura K. Kageyama S. Yue S. Huang J. Fujii T. Ke B. et al.Heme oxygenase-1 regulates sirtuin-1-autophagy pathway in liver transplantation: From mouse to human.Am J Transplant. 2017; https://doi.org/10.1111/ajt.14586Crossref PubMed Scopus (47) Google Scholar on the regulation of macrophage activation and autophagy by macrophage heme oxygenase (HO-1) in hepatic IRI. In these two studies, the authors innovatively assessed human liver transplants post-reperfusion, primary murine macrophages and livers of myeloid-specific HO-1 (Hmox1) gene mutant mice stimulated by IRI. These studies demonstrated that macrophage HO-1 is a key determinant that regulates macrophage activation via the SIRT1-p53 signalling axis and SIRT1-autophagy during IRI, and that genetic overexpression of HO-1 in macrophages can decrease orthotopic liver transplantation damage; thus, they have provided novel mechanistic and therapeutic insights regarding hepatic IRI. It is well known that ischemia leads to multifactorial initial parenchymal cell death, whereas reperfusion is thought to cause additional damage to hepatocytes via metabolic disturbances and the induction of profound innate immune responses.[3]Zhai Y. Petrowsky H. Hong J.C. Busuttil R.W. Kupiec-Weglinski J.W. Ischaemia-reperfusion injury in liver transplantation–from bench to bedside.Nat Rev Gastroenterol Hepatol. 2013; 10: 79-89Crossref PubMed Scopus (499) Google Scholar Nakamura et al.1Nakamura K. Zhang M. Kageyama S. Ke B. Fujii T. Sosa R.A. et al.Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury.J Hepatol. 2017; 67: 1232-1242Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar, 2Nakamura K. Kageyama S. Yue S. Huang J. Fujii T. Ke B. et al.Heme oxygenase-1 regulates sirtuin-1-autophagy pathway in liver transplantation: From mouse to human.Am J Transplant. 2017; https://doi.org/10.1111/ajt.14586Crossref PubMed Scopus (47) Google Scholar mainly determined the functions of HO-1 in innate immune responses during hepatic IRI by analysing how post-transplant HO-1 levels correlated with patients’ liver function and survival rate. They found that high HO-1 levels correlated with well-preserved hepatocellular function and enhanced SIRT1/LC3B expression. By using clinical hepatic biopsy specimens from orthotopic liver transplantation patients, these authors identified a unique strategy to study the mechanisms of IRI; remarkably few studies have used human post-transplant specimens. Furthermore, by adopting a mouse model, they showed that myeloid-specific HO-1 deficiency remarkably aggravated hepatic IRI and induced a pronounced hepatic inflammatory response during liver IRI but that SIRT1 reversed these adverse effects by restoring p19/p53 signalling. The authors concluded that in macrophages, HO-1 protects against hepatic IRI. Although Nakamura et al.1Nakamura K. Zhang M. Kageyama S. Ke B. Fujii T. Sosa R.A. et al.Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury.J Hepatol. 2017; 67: 1232-1242Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar, 2Nakamura K. Kageyama S. Yue S. Huang J. Fujii T. Ke B. et al.Heme oxygenase-1 regulates sirtuin-1-autophagy pathway in liver transplantation: From mouse to human.Am J Transplant. 2017; https://doi.org/10.1111/ajt.14586Crossref PubMed Scopus (47) Google Scholar concluded that HO-1 plays a key role in activating SIRT1-autophagy by macrophages in hepatic IRI, they did not provide data regarding the function of HO-1 in other cell types that express this protein, such as hepatocytes and liver sinusoidal endothelial cells. Indeed, Qu et al.[4]Qu S. Yuan B. Zhang H. Huang H. Zeng Z. Yang S. et al.Heme oxygenase 1 attenuates hypoxia-reoxygenation injury in mice liver sinusoidal endothelial cells.Transplantation. 2018; 102: 426-432PubMed Google Scholar recently identified a protective role of HO-1 in liver sinusoidal endothelial cells during hypoxia/reoxygenation injury. Moreover, both our research group and other groups have found markedly increased HO-1 expression in hepatocytes during hepatic IRI and in vitro hypoxia/reoxygenation injuries.5Xu D. Chen L. Chen X. Wen Y. Yu C. Yao J. et al.The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.Cell Death Dis. 2017; 8e2983Crossref PubMed Scopus (81) Google Scholar, 6Liu A. Huang L. Guo E. Li R. Yang J. Li A. et al.Baicalein pretreatment reduces liver ischemia/reperfusion injury via induction of autophagy in rats.Sci Rep. 2016; 625042Crossref PubMed Scopus (50) Google Scholar We have identified cytoprotective effects of HO-1 in hepatic IRI, as HO-1 expression leads to enhanced autophagy in hepatocytes. Mechanistically, we demonstrated that HO-1 enhanced autophagy in hepatocytes by increasing the clearance of damaged mitochondria and reducing mitochondrial DNA release and overproduction of reactive oxygen species during the early stages of hepatic IRI, leading to reductions in damage-associated molecular pattern-induced inflammatory responses and subsequent secondary hepatocyte injury. Therefore, in addition to the essential functions of HO-1 in modulating autophagy in macrophages, HO-1 in parenchymal cells (hepatocytes) also plays important roles during earlier stages of hepatic IRI in protecting the liver from IRI. Additional research involving hepatocyte-specific HO-1 knockout and transgenic mice subjected to hepatic IRI will be helpful for further elucidating the protective role of HO-1 in hepatocytes. The authors received no financial support to produce this manuscript. The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details. Dongwei Xu and Min Xu: design of the study and writing of the manuscript. Xiaoni Kong and Qiang Xia: revision of the manuscript and final approval. Download .pdf (.13 MB) Help with pdf files Supplementary data

Protective Effects of Heme Oxygenase 1 During Ischemia-Reperfusion Injury: Hepatocytes or Non-Parenchymal Cells?